Table 3 Global ventricular measures in patients with and without ischemia.

From: Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy

Characteristics—n (%) or mean (SD)

All patients

No ischemia

Ischemia

P value

105

58 (55.2)

47 (44.8)

Apical hypertrophy

17 (16.2)

9 (15.5)

8 (17)

0.3

LVEDV (indexed)

32.5 (8)

32.4 (9)

32.5 (7.8)

0.9

LVESV (indexed)

14.7 (9.6)

15.3 (9.4)

13.9 (10.5)

0.2

LV mass (indexed)

105 (34.5)

107.4 (36.2)

109.1 (32.7)

0.8

LVEF

75.8 (7.4)

75.2 (7.1)

76.6 (7.7)

0.3

RVEDV (indexed)

63.6 (22.4)

64.7 (25.8)

63.6 (19.4)

0.3

RVESV (indexed)

23.1 (13.6)

24.6 (14.7)

29.9 (12.2)

0.4

RVEF

63. (9.5)

64 (10.1)

62.1 (9.4)

0.8

ECV (%)

0.29 (0.041)

0.28 (0.037)

0.30 (0.044)

0.04

Total LGE burden (% of LV mass)

4 (8.5)

4 (8.3)

5 (10)

0.4

  1. The p values are results for the t-test, Mann Whitney U test, or the chi-square test.
  2. ECV, extracellular ejection fraction; LGE, late Gadolinium enhancement; LVEDV, left ventricular end diastolic volume; LVESV, left ventricular end systolic volume; LVEF, left ventricular ejection fraction; RVEDV, right ventricular end diastolic volume; RVESV, right ventricular end systolic volume; RVEF, right ventricular ejection fraction.